ANTIPLATELET DRUGS WITH EMPHASIS ON PROSTANOIDS

被引：0

|

作者：

ADAIKAN, PG

LOGANATH, A

KARIM, SMM

RATNAM, SS

机构：

来源：

ASIA PACIFIC JOURNAL OF PHARMACOLOGY | 1987年 / 2卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：61 / 78

页数：18

相关论文

共 50 条

[21] Pharmacogenetics and antiplatelet drugs
Fontana, P
Reny, JL
REVUE DE MEDECINE INTERNE, 2005, 26 (09): : 725 - 732
[22] Antiplatelet Drugs in the Elderly
David Green
Paula Podrazik
Journal of Thrombosis and Thrombolysis, 2000, 9 : 115 - 116
[23] CARDIOPROTECTIVE EFFECTS OF PROSTANOIDS, PEPTIDES AND ANALGESIC DRUGS
MENTZ, P
GIESSLER, C
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 : S79 - S79
[24] Augmentation of thrombolysis with antiplatelet drugs
Coller, BS
CORONARY ARTERY DISEASE, 1995, 6 (12) : 911 - 914
[25] Antiplatelet drugs in cardiovascular diseases
Weston, C
Rao, U
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (10) : 898 - 905
[26] Clinical pharmacology of antiplatelet drugs
Gelbenegger, Georg
Jilma, Bernd
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (10) : 1177 - 1197
[27] Antiplatelet drugs and the smokers' paradox
不详
AUSTRALIAN PRESCRIBER, 2015, 38 (04) : 112 - +
[28] Antiplatelet Drugs and Endothelial Function
Higashi, Yukihito
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (10) : 1147 - 1149
[29] Renal function and antiplatelet drugs
Keltai, Matyas M. D.
CORONARY ARTERY DISEASE: 2011 UPDATE: FROM PREVENTION TO INTERVENTION, 2011, : 263 - 268
[30] Antiplatelet drugs and liver fibrosis
Czajka, Pamela
Przybylkowski, Adam
Nowak, Anna
Postula, Marek
Wolska, Marta
Mirowska-Guzel, Dagmara
Czlonkowska, Anna
Eyileten, Ceren
PLATELETS, 2022, 33 (02) : 219 - 228

← 1 2 3 4 5 →